The DOI matches its Crossref record; 88 of the 91 references it cites were found in a registry or an index.
Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity.
Abstract
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine disease characterized by clinical or laboratorial hyperandrogenism, oligo-anovulation and metabolic abnormalities, including insulin resistance, excessive weight or obesity, type II diabetes, dyslipidemia and an increased risk of cardiovascular disease. The most significant clinical manifestation of PCOS is hyperandrogenism. Excess androgen profoundly affects granulosa cell function and follicular development via complex mechanisms that lead to obesity and insulin resistance. Most PCOS patients with hyperandrogenism have steroid secretion defects that result in abnormal folliculogenesis and failed dominant follicle selection. Hyperandrogenism induces obesity, hairy, acne, and androgenetic alopecia. These symptoms can bring great psychological stress to women. Drugs such as combined oral contraceptive pills, metformin, pioglitazone and low-dose spironolactone help improve pregnancy rates by decreasing androgen levels in vivo. Notably, PCOS is heterogeneous, and hyperandrogenism is not the only pathogenic factor. Obesity and insulin resistance aggravate the symptoms of hyperandrogenism, forming a vicious cycle that promotes PCOS development. Although numerous studies have been conducted, the definitive pathogenic mechanisms of PCOS remain uncertain. This review summarizes and discusses previous and recent findings regarding the relationship between hyperandrogenism, insulin resistance, obesity and PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Women with PCOS are also at higher risk for metabolic complications, including type 2 diabetes, dyslipidemia, and cardiovascular disease [6].”
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Laven, J. S. E., Mulders, A. G. M. G. J., Visser, J. A., Themmen, A. P. N., de Jong, F. H., & Fauser, B. C. J. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030932 · Cited by 519
Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283
11-Oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome
O’Reilly, M. W., Kempegowda, P., Jenkinson, C., Taylor, A. E., Quanson, J. L., Storbeck, K.-H., & Arlt, W. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3285 · Cited by 267
Jedel, E., Labrie, F., Odén, A., Holm, G., Nilsson, L., Janson, P. O., Lind, A., Ohlsson, C., & Stener‐Victorin, E. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00495.2010 · Cited by 228
Adiponectin Induces Periovulatory Changes in Ovarian Follicular Cells
Ledoux, S., Campos, D. B., Lopes, F. L., Dobias-Goff, M., Palin, M., & Murphy, B. D. (2006) · Endocrinology · doi:10.1210/en.2006-0679 · Cited by 188
Corbould, A. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07070 · Cited by 184
Cortón, M., Botella-Carretero, J. I., Benguría, A., Villuendas, G., Zaballos, Á., Millán, J. L. S., Escobar-Morreale, H. F., & Peral, B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1665 · Cited by 174
Research works printed but not linked: 1
- Araújo, 2018, The obesogen tributyltin induces abnormal ovarian adipogenesis in adult female rats, Toxicol. Lett., 11, 327
Cited by
Sorted by citations
Items 301–400 of 527
Research progress on insulin resistance in polycystic ovary syndrome
Qi, Y.-B., Yi, P., & Fu, X. (2025) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000131 · Cited by 5
Wang, Z., Teng, X., Liu, Y., Shen, Y., Ma, L., & Chen, Y. X. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01975-4 · Cited by 3
Self-citationObesity: A Modulator in Acne Management
Claudel, J. P., Ballanger, F., Auffret, N., Leccia, M. ‐., & Dréno, B. (2025) · Acta Dermato Venereologica · doi:10.2340/actadv.v105.43945 · Cited by 2
Zhang, Y., Chen, M., Zhou, Z. G., Guo, Y., Zheng, L., Yu, Y., Liu, J., Zhou, Y., Lu, H., Yao, S., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1517934 · Cited by 2
Adolescent hyperandrogenism: diagnostic challenges and therapeutic approaches
Concepción‐Zavaleta, M. J., Fuentes‐Mendoza, J. M., Zavaleta‐Gutiérrez, F. E., Arias-Cantor, B. Y., Figueredo-Rueda, M. V., Arroyo, J., & Paz‐Ibarra, J. (2025) · World Journal of Pediatrics · doi:10.1007/s12519-025-00972-w · Cited by 2
Qin, H., Liu, H., Sun, J., Cai, L., Tan, Y. Q., Li, M., Xiao, Y., & Li, L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332082 · Cited by 2
Bhati, P., Haloi, P., Munjal, K., & Chitme, H. R. (2025) · Hormones and Behavior · doi:10.1016/j.yhbeh.2025.105844 · Cited by 2
Üçgül, E., Menekşe, B., Demirci, H., & Çakal, E. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02761-8 · Cited by 2
Obesity and infertility: a double whammy
Sokwalla, S., Busaidy, S., & Das, G. (2025) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000944 · Cited by 2
Sandeep, P. M., Muhammed, S. A. H., Mohan, S., Lakshmanan, M., Bovee, T. F. H., & Sreejith, K. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.107025 · Cited by 2
Bariatric surgery as a treatment of polycystic ovary syndrome: a systematic review and meta-analysis
Mirghani, H. O., & Shaman, A. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682379 · Cited by 2
Emam, S. R., Ibrahim, M. A., Youssef, F. S., Khattab, M. S., El‐Shiekh, R. A., Ghandour, R. A., Hozyen, H. F., Zakaria, M., Abdel-Sattar, E. A., & Mouneir, S. M. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02158-w · Cited by 2
Xu, H., Zhang, H., Yang, R., Xie, X., Cao, Z., Zhao, Y. (., Lin, H., Lu, D., Bischoff, F. Z., Zhang, X., et al. (2026) · The Innovation Nutrition · doi:10.59717/j.xinn-nutri.2026.100004 · Cited by 2
The Novelty of miRNAs as a Clinical Biomarker for the Management of PCOS
Alhamdan, R., & Hernandez-Medrano, J. H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104386 · Cited by 2
Family History of Diabetes: An Important Risk Factor for Developing PCOS
Fayyaz, S., Butt, M. B., Khan, S., Ali, A., Abbas, H. Y., & Sunita (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221641204 · Cited by 2
Hegde, P., Shetty, P. K., Shetty, S. S., Manjeera, L., Shetty, D. P., & Kumari, S. (2022) · Biomedicine · doi:10.51248/.v42i3.1415 · Cited by 2
Polycystic Ovary Syndrome in Adolescent Period: Physical, Metabolic, and Hormonal Features
Harı, M., Gen, R., Koyuncu, M. B., Durukan, H., & Çimen, M. B. Y. (2022) · Düzce Tıp Fakültesi Dergisi · doi:10.18678/dtfd.1089043 · Cited by 2
Bhattacharjee, N., Sarkar, S., & Giri, B. (2022) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v12i5.5582 · Cited by 2
Polycystic ovarian syndrome and microbiome: Implications for women’s health
Patel, N., Singh, D., Lokary, V., & Shaker, I. A. (2023) · Journal of Medical and Scientific Research · doi:10.17727/jmsr.2023/11-10 · Cited by 2
Lu, J., Xuan, F., Chen, A., Jin, R., Zhou, W., Ye, Y., & Ren, Y. (2023) · Endokrynologia Polska · doi:10.5603/ep.a2023.0020 · Cited by 2
Ma, N., Zhou, J., Zhou, Z., Wan, B., & Lu, W. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01400-8 · Cited by 2
Berberine interacts with gut microbiota and its potential therapy for polycystic ovary syndrome
Zhu, T., & Li, X. (2023) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13814 · Cited by 2
Ghavi, F., Shakeri, F., & Abdolahian, S. (2023) · PubMed Central · doi:10.22038/ajp.2022.21389 · Cited by 2
Are ABO/Rh blood groups A risk factor for polycystic ovary syndrome?
Doğan, Ö. (2023) · Medicine · doi:10.1097/md.0000000000034944 · Cited by 2
Zeng, Z., Li, J., Wang, X., Yi, S., Bi, Y., Mo, D., Liu, B., Fu, X., Yang, Y., & Ma, W. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20095 · Cited by 2
Abu‐Zaid, A., Bukhari, I. A., Alyousef, A., Baradwan, S., Muaythir, N. B., Almudaymigh, Y., Abuzaid, M., Saleh, S. A. K., Adly, H. M., & Alomar, O. (2023) · PharmaNutrition · doi:10.1016/j.phanu.2023.100358 · Cited by 2
The Relationship between Anti-mullerian Hormone and Prolactin Levels in Polycystic Ovarian Syndrome
Güngör, K. (2023) · The Anatolian Journal of Family Medicine · doi:10.5505/anatoljfm.2023.00821 · Cited by 2
Pan, Y., Yang, C., Sun, Y., Zhang, S.-M., Xue, T., Li, F., & Fu, D. (2024) · Steroids · doi:10.1016/j.steroids.2024.109516 · Cited by 2
Shangguan, F., Liu, H., Guo, Y., Yu, J., Liang, Y., Yu, H., Su, Y., & Li, Z. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-084815 · Cited by 2
Alarslan, P., & Doruk, M. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15020070 · Cited by 3
Areloegbe, S. E. J., Atuma, C. L., Aturamu, A., Ajadi, I. O., Adelekan, O. E., Ajadi, M. B., Akintayo, C. O., Omoruyi, G. O., Onyekweli, S. O., Anifowose, O. F., et al. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04157-5 · Cited by 2
Nordtvedt, E., Kessler, J., Ebbing, C., Acharya, G., Løvvik, T., Salvesen, K., Salvesen, Ø., Vanky, E., & Kahrs, B. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07866-9 · Cited by 2
11- Oxygenated Androgens Inhibit Brown Adipose Tissue Differentiation
Yuan, Y., Steenbergen, J., Goulart, A. D. O. S., Sabaté-Pérez, A., & Visser, J. A. (2025) · Endocrinology · doi:10.1210/endocr/bqaf172 · Cited by 1
Татарчук, Т. Ф., Tutchenko, T. М., & Бурка, О. А. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103808 · Cited by 2
Zebda, H., & Nori, W. (2023) · Italian Journal of Gynaecology and Obstetrics · doi:10.36129/jog.2023.106 · Cited by 2
Polycystic Ovaries and Associated Clinical and Biochemical Features in Young Women
Tahir, F. N., Kanwal, S., Safdar, M., Malik, A. A., Hakim, S., & Ashraf, M. N. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023173693 · Cited by 2
Perspectivas atuais sobre Síndrome dos Ovários Policísticos: abordagens diagnósticas e terapêuticas
Nobre, P. V. C., Júnior, J. D. A. A., Macena, L. B., da Rocha, M. S. M. V., Costa, K. E. N., Melo, T. R. B., Silva, L. S. R., Sampaio, M. T. C. N., Meneses, J. V. S., Cordeiro, K. I. C., et al. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n3p2500-2510 · Cited by 5
Cai, M., Ni, Z., Yao, Y., Yu, J. Z., Yu, C., Zhou, L., & Zhai, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1304673/v1 · Cited by 2
Washington, J. K., Manivasakan, J., Kala, P. G., & Sasikala, R. (2022) · Gynecology and Obstetrics Clinical Medicine · doi:10.1016/j.gocm.2022.11.003 · Cited by 1
PCOS as a generational disease - risks to mother and children
Gendek, K., Kozłowska, A., Dalmata, W., Gąbka, I., Dąbrowski, J., & Korzeniowska, A. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.42.01.007 · Cited by 1
Liu, H., Fang, X., Ma, Q., Wang, M., Hao, X., & Wang, G. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2326102 · Cited by 1
Mashhadi, F., Ghaebi, N. K., Roudi, F., & Nematy, M. (2024) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-024-01997-3 · Cited by 1
Farzipour, S., Jalilvand, F., Amani, F., Sadeghi-Movahhed, F., & Shahmohammad-Ardabili, H. (2024) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20242058 · Cited by 1
Ling, S., Huang, L.-Y., Lia, T., Xie, D., Xiao, Q., Tian, C., & Li, Q. (2024) · Medicine · doi:10.1097/md.0000000000040162 · Cited by 1
Dong, F., Zhang, W., Sun, B., Niu, W., Zhai, J., Guo, Y., & Wang, F. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673357582241223070335 · Cited by 1
Association of paraoxonase-1 108 C >T gene polymorphism with polycystic ovarian syndrome
Kadhum, H. H., Alizzi, F. J., Al-Mayah, Q. S., & Timimi, R. J. A. (2025) · Journal of Research in Pharmacy · doi:10.12991/jrespharm.1644613 · Cited by 1
Effect of metformin on the endometrial proteome of diet-induced obese mice
Malliou-Becher, M.-N., Turnwald, E., Skupin, L., Kretschmer, T., Mesaros, A., Purrio, M., Wohlfarth, M., Handwerk, M., Kalis, S., Gründemann, D., et al. (2025) · Journal of Molecular Endocrinology · doi:10.1530/jme-24-0098 · Cited by 1
Cuéllar-Rodríguez, V., Pérez-Londoño, A., Guatibonza-García, V., Betancourt-Villamizar, C., & Mendivil, C. O. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-001075 · Cited by 1
Lei, X., Liu, X., Qu, Y., & Huang, Y. (2025) · Brain and Behavior · doi:10.1002/brb3.70745 · Cited by 1
Farooq, U., Hasan, N., Ali, A., Hasan, N., Mohapatra, S., Jain, P., Mirza, M. A., Ali, A., & Iqbal, Z. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2551321 · Cited by 1
Zheng, L., Ren, Q., & Tan, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1650311 · Cited by 1
Yang, J., Zhang, X., Zhang, H., Guo, X., Ren, F., & Dong, C. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s552619 · Cited by 1
Zahra, M., Shah, M., Iqbal, F., Zubair, T., Habib, R., & Zulfiqar, F. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04626-6 · Cited by 2
Lee, B., Lee, G., Choi, L. Y., Kwon, S., Jeon, Y., Kim, M. H., & Kim, S. H. (2025) · Food Science and Biotechnology · doi:10.1007/s10068-025-02019-2 · Cited by 1
de Kroon, R. W. P. M., den Heijer, M., Haarman, S. J., Verdaasdonk, R. M., & Heijboer, A. C. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s543359 · Cited by 1
Alarslan, P., & Doruk, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682910 · Cited by 1
Atılgan, Z. T. D., Tok, Ö., & Göktaş, Z. (2025) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1177/1973798x251377712 · Cited by 1
Hosein, M.-R., & Housein, Z. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11436-3 · Cited by 1
Abduljabbar, H., Jamal, M., & Esmat, A. (2026) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010433981251031050335 · Cited by 1
Zhang, W., Xue, J., Wang, J., Ni, D., Zhou, W., Wang, B., Shi, J., & Wang, A. (2026) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2025.210 · Cited by 1
Jafarnejad, A., Pourrajab, B., Mighani, S., Hajiluian, G., Nameni, G., Dabbaghabdollahi, P., Ebrahimi, M. A., & Eftekharian, M. (2026) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2026.100655 · Cited by 1
Diagnostic Criteria and Genetic Basis of Polycystic Ovary Syndrome: A Narrative Review
Cepero-González, M. D. L. A., Aguilar-Galarza, A., Rodríguez-García, V. M., García-Gasca, T., & Moreno‐Celis, U. (2026) · Metabolites · doi:10.3390/metabo16040277 · Cited by 2
Sharma, R., & Shain, D. H. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48050526 · Cited by 1
The Relationship Between 2D:4D Digit Ratio and Polycystic Ovary Syndrome: A Systematic Review
Emül, T. G., & Serin, E. K. (2026) · American Journal of Human Biology · doi:10.1002/ajhb.70288 · Cited by 1
The role of genetic and epigenetic factors in developing polycystic ovary syndrome
Koval, Y. E., Дмитриевна, К. Т., Игнатко, И. В., Bakhtiyarov, K. R., Gilmutdinova, I., & Владимировна, В. Е. (2026) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2026.766 · Cited by 1
Chen, X., Liu, Y., Chen, D., & Chen, L. (2026) · PeerJ · doi:10.7717/peerj.21507 · Cited by 1
Self-citationJamshidian, S., & Jalilvand, F. (2026) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70442 · Cited by 1
Pathogenesis of Polycystic Ovary Syndrome
朱, 海. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.114244 · Cited by 1
Adolescence: A High-Risk Period for PCOS Development?
Sultan, C., Gaspari, L., Hamamah, S., & Paris, F. (2021) · ISGE series · doi:10.1007/978-3-030-63650-0_2 · Cited by 1
Myo-inositol in polycystic ovary syndrome: a systematic review and positioning of its use
Filho, D. R., Nogueira‐de‐Almeida, C. A., & Zotarelli-Filho, I. J. (2022) · International Journal of Nutrology · doi:10.54448/ijn22201 · Cited by 1
Association Between Gestational Diabetes History with Endometrial Hyperplasia and Cancer
Bouzari, Z., Mohammadi, T., Ranaei, M., Hajian‐Tilaki, K., & Ghanbarpour, A. (2022) · Journal of Obstetrics Gynecology and Cancer Research · doi:10.30699/jogcr.7.5.414 · Cited by 1
Potential role of endoplasmic reticulum stress in the pathophysiology of polycystic ovary syndrome
Alexandre‐Santos, B., Martins, F. F. T. R., Gonçalves, L. D. S., Guimarães, C. D. O., Carla-Ruggiero, F., & Magliano, D. C. (2022) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2022-0051 · Cited by 2
Rabeh, N. M., El-Masry, H. G., Ragheb, E. M., & Mahmoud, S. (2022) · Egyptian Journal of Nutrition and Health · doi:10.21608/ejnh.2022.259240 · Cited by 1
Determination of Oxidative Stress Markers in Women with Polycystic Ovarian Syndrome
Saleh, A. M. (2023) · E3S Web of Conferences · doi:10.1051/e3sconf/202339101117 · Cited by 1
FETAL METABOLIC PROGRAMMING IN THE ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME
Silva, M. P. L. D., & Vargas, R. (2023) · Revista Contemporânea · doi:10.56083/rcv3n8-028 · Cited by 1
Nutritional and clinical profile of women with polycystic ovary syndrome
da Luz, B. C., Martins, P. E. B., da Silva, A. A. M., Cavalcante, T. C. F., Tomiya, M. T. O., & de Souza, T. K. M. (2023) · Seven Editora eBooks · doi:10.56238/connexpemultidisdevolpfut-144 · Cited by 1
杨, 宇. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1391943 · Cited by 1
Parveen, S., Iram, N., Saeed, B. Z., Yaqub, U., & Niazi, N. K. (2023) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v73i3.9081 · Cited by 1
Ye, S., Huang, Y., Lu, Y., Li, X., Ye, M., Lu, H., Shi, J., Huang, J., & Cai, H. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0451 · Cited by 1
The Role of ADAM17 in PCOS Pathogenesis: A review Paper
Preap, B., Hong, K., Chen, J., & Chen, J. (2024) · Journal of Health Science and Medical Therapy · doi:10.59653/jhsmt.v2i02.632 · Cited by 1
Ивановна, А. Е., Yarmolinskaya, M. I., & Osinovskaya, N. S. (2023) · Journal of obstetrics and women s diseases · doi:10.17816/jowd611015 · Cited by 2
Nutritional Management of Polycystic Ovary Syndrome: Insights into Diet and Nutrition Strategies
Jan, B., Ahmad, S., Ibrahim, M., & Choudhary, B. (2024) · Natural Resources for Human Health · doi:10.53365/nrfhh/183616 · Cited by 1
Systematic Review on the Various Clinical Features of Polycystic Ovary Syndrome (PCOS) Patients
Farhana, A. A., & Shi, J. (2024) · SSR Institute of International Journal of Life Sciences · doi:10.21276/ssr-iijls.2024.10.2.22 · Cited by 1
Zheng, X., Zhou, C., Xu, W., Jia, J.-J., Li, B., Lv, G., & Chen, S. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2368845 · Cited by 1
Polycystic Ovarian Syndrome: Current Insights
Naidu, S. J. K., Ramdin, S., Naicker, T., Moodley, J., Naidoo, G., & Govender, N. (2024) · Biomedical visualization · doi:10.1007/978-3-031-68501-9_8 · Cited by 1
Diagnosing polycystic ovary syndrome at a tertiary level hospital in Latin America
López, J. A. G., Contreras, O. E. R., Hernández, E. F. M., Moreno, J. A. G., León, H. C., Valero, V. C., Sanguino, A. J. S., Torres, A. S., & Agudelo, J. S. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70026 · Cited by 1
Xie, Y., Zeng, Z., Zhang, J., Han, Q., Song, C., Jin, S., & Zhao, M. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1595602 · Cited by 1
Self-citationCORRELATION BETWEEN LEPTIN, INSULIN AND POLYCYSTIC OVARY SYNDROME
Mohamed, A. F., Zakaria, A. E.-M. M., Ali, M. A. E.-M., & Motaal, A. O. A. (2021) · Al-Azhar Medical Journal · doi:10.21608/amj.2021.178293 · Cited by 1
Angu, K., Sharma, R., Alauddin, W., Bashir, M., & Aaghaz, S. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns1.6508 · Cited by 1
Abou-Seido, N., Yaqub, M., & Desouza, A. (2023) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.476 · Cited by 1
TERAPIA NUTRICIONAL EM PACIENTES ONCOLÓGICOS
da Cruz, L. P. L., Neto, J. G. D. O., Nascimento, W. S. M., Oliveira, A. C. V., Muniz, T. L., Silva, E. C. M. M., de Aragão, M. A. F., Sales, P. L. P., dos Santos, N. C., dos Santos, W. R., et al. (2023) · doi:10.56161/sci.ed.20230900c6 · Cited by 1
Chaika, V. V. (2021) · Актуальні питання педіатрії акушерства та гінекології · doi:10.11603/24116-4944.2020.2.11860
Cheshmeh, S., Ghayyem, M., Khamooshi, F., Heydarzadeh, N., Hojati, N., Mosaieby, E., Moradi, S., & Pasdar, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-245937/v1
Zhang, Y., Ma, J., Zhu, Y.-T., Wang, Y., Chen, W.-Q., Sun, X., Zhang, W., Wang, C.-Y., & Ding, C. (2021) · Research Square · doi:10.21203/rs.3.rs-642886/v1
Kaminsky, V., & Chaika, V. K. (2021) · Journal of Education Health and Sport · doi:10.12775/jehs.2021.11.10.026
Association of Primary Subfertility in Polycystic Ovarian Syndrome with BMI and Waist Circumference
Waheed, F., Muhabat, Q., Bhatti, U., Effendi, S., Koshila, & Mumtaz, F. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2115113531
INFLAMMATORY STATUS IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME IN GAZA STRIP
Taha, M. (2022) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2022.239467
Kılıç, B. Ş., Seyisoğlu, H., & Atakul, N. (2022) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.galenos.2021.25349
Kyrou, I., Kahal, H., Weickert, M. O., Barber, T. M., & Randeva, H. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00029-8
Rabeh, N. M., El-Masry, H. G., Ragheb, E. M., & Mahmoud, S. F. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns6.9758
Metadata
- Authors
- Zeng, X., Xie, Y.-J., Liu, Y.-T., Long, S.-L., & Mo, Z.-C.
- Affiliations
- University of South China (CN)
- Corresponding author
- Long, Shuang-lian
- ORCID
- Zeng, Xin
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 502
- Pages
- 214-221
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2987017313
- Cited by
- 525
- References
- 91
- Citations by year
- 2026: 57 · 2025: 108 · 2024: 99 · 2023: 112 · 2022: 84 · 2021: 49 · 2020: 16
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinica Chimica Acta (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Natural Sciences Foundation of Hunan Province (2017JJ2233)
- Key Lab for Clinical Anatomy & Reproductive Medicine of Hengyang City (2017KJ182)
- University of South China (2018XJXZ373)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, hyperandrogenism, insulin resistance, obesity, androgenetic alopecia, acne, oligoanovulation, folliculogenesis, dominant follicle selection, metformin, spironolactone, pioglitazone, oral contraceptives, type 2 diabetes, cardiovascular risk
- MeSH terms
- Pioglitazone, Androgens, Female, Humans, Hypoglycemic Agents, Insulin Resistance, Metformin, Obesity, Polycystic Ovary Syndrome, Spironolactone, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
